These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27423983)

  • 1. Synthesis of 17β-N-arylcarbamoylandrost-4-en-3-one derivatives and their anti-proliferative effect on human androgen-sensitive LNCaP cell line.
    Cortés-Benítez F; Cabeza M; Ramírez-Apan MT; Alvarez-Manrique B; Bratoeff E
    Eur J Med Chem; 2016 Oct; 121():737-746. PubMed ID: 27423983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.
    Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM
    Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative effect of androst-4-ene-3,17-dione and its metabolites in the androgen-sensitive LNCaP cell line.
    Laplante Y; Poirier D
    Steroids; 2008 Mar; 73(3):266-71. PubMed ID: 18082864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of some epoxy and/or N-oxy 17-picolyl and 17-picolinylidene-androst-5-ene derivatives and evaluation of their biological activity.
    Djurendić E; Daljev J; Sakac M; Canadi J; Santa SJ; Andrić S; Klisurić O; Kojić V; Bogdanović G; Djurendić-Brenesel M; Novaković S; Gasi KP
    Steroids; 2008 Jan; 73(1):129-38. PubMed ID: 17963806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of methoxycarbonylpyrazolylandrostene derivatives, and their potential inhibitory effect on androgen biosynthesis and cell proliferation.
    Szabó N; Iványi Z; Szécsi M; Julesz J; Mernyák E; Huber J; Wölfling J; Minorics R; Zupkó I; Schneider G
    Steroids; 2015 Jun; 98():143-52. PubMed ID: 25804762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro antiproliferative activity of novel androst-5-ene triazolyl and tetrazolyl derivatives.
    Kádár Z; Kovács D; Frank É; Schneider G; Huber J; Zupkó I; Bartók T; Wölfling J
    Molecules; 2011 Jun; 16(6):4786-806. PubMed ID: 21659965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
    Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
    Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, antiproliferative activity, acute toxicity and assessment of the antiandrogenic activities of new androstane derivatives.
    Dhingra N; Bhardwaj TR; Mehta N; Mukhopadhyay T; Kumar A; Kumar M
    Arch Pharm Res; 2011 Jul; 34(7):1055-63. PubMed ID: 21811911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of some 17-picolyl and 17-picolinylidene androst-5-ene derivatives.
    Gasi KM; Brenesel MDj; Djurendić EA; Sakac MN; Canadi JJ; Daljev JJ; Armbruster T; Andrić S; Sladić DM; Bozić TT; Novaković IT; Juranić ZD
    Steroids; 2007 Jan; 72(1):31-40. PubMed ID: 17118415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists.
    Lao K; Sun J; Wang C; Wang Y; You Q; Xiao H; Xiang H
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4212-4217. PubMed ID: 28757062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP.
    Olea N; Sakabe K; Soto AM; Sonnenschein C
    Endocrinology; 1990 Mar; 126(3):1457-63. PubMed ID: 2307113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
    Chen J; Wang WQ; Lin SX
    J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate.
    Janssen T; Darro F; Petein M; Raviv G; Pasteels JL; Kiss R; Schulman CC
    Cancer; 1996 Jan; 77(1):144-9. PubMed ID: 8630922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
    Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M
    Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
    Day JM; Tutill HJ; Foster PA; Bailey HV; Heaton WB; Sharland CM; Vicker N; Potter BV; Purohit A; Reed MJ
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):251-8. PubMed ID: 18786604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
    Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
    J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q; Titus MA; Fung KM; Lin HK
    J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.
    Vue B; Zhang S; Zhang X; Parisis K; Zhang Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2016 Feb; 109():36-46. PubMed ID: 26748997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of androstene oxime-nitrogen mustard bioconjugates as potent antineoplastic agents.
    Acharya PC; Bansal R
    Steroids; 2017 Jul; 123():73-83. PubMed ID: 28450070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.